Skip to main content
GutCited

Lactobacillus acidophilus لـ Irritable Bowel Syndrome (IBS)

B

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dacidophilus\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

Key Study Findings

Randomized Controlled Trial n=200 12 weeks Double-blind
Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable …
Dose: None مقابل: placebo Outcome: IBS-Global Improvement Scale response التأثير: 19.3% vs 8.9% response at day 28 p=0.048

المجتمع المدروس: adults with non-constipated irritable bowel syndrome

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None مقابل: placebo Outcome: quality of life, depression, and anxiety in IBS … التأثير: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

المجتمع المدروس: patients with irritable bowel syndrome

Randomized Controlled Trial n=61 12 weeks Double-blind
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel …
Dose: None مقابل: Placebo Outcome: IBS-SSS (100-point reduction) التأثير: 45% active vs 33% placebo (P=0.42) P=0.42

المجتمع المدروس: IBD patients with IBS symptoms in remission

Randomized Controlled Trial n=110 12 weeks Double-blind
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for …
Dose: 10^9 CFU L. acidophilus LA-5 + L. paracasei daily مقابل: Placebo cultured milk Outcome: Depression risk and serotonin levels in IBS patients التأثير: None <0.001 (depression score)

المجتمع المدروس: IBS patients with normal mood and subthreshold depression

In Vitro
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal …
Dose: None مقابل: None Outcome: Colitis severity التأثير: None None

المجتمع المدروس: Crohn's disease patients

Randomized Controlled Trial 4 weeks
Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group …
Dose: 2 g مقابل: Placebo Outcome: Constipation symptoms التأثير: None P = 0.005

المجتمع المدروس: IBS patients

Key Statistics

3

الدراسات

350

المشاركون

Positive

B

التقييم

Referenced Papers

Scientific reports 2024 10 اقتباسات
Diseases (Basel, Switzerland) 2018 50 اقتباسات
PloS one 2012 445 اقتباسات
Alimentary pharmacology & … 2010 4 اقتباسات
Neurogastroenterology and motility 2009 81 اقتباسات
Current opinion in … 2008 68 اقتباسات
Minerva gastroenterologica e … 2006 22 اقتباسات
Journal of clinical … 2004 298 اقتباسات
Journal of clinical … 2004 205 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
1-10 billion CFU/day
ibssupport:
10 billion CFU/day for 4-8 weeks
lactosesupport:
1-2 billion CFU with dairy consumption

الحد الأعلى: Generally well-tolerated up to 20 billion CFU/day

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None 12 weeks Positive 200
None -- Positive 3154
None 12 weeks Neutral 61
10^9 CFU L. acidophilus LA-5 + L. paracasei daily 12 weeks Positive 110
None -- Positive --
2 g 4 weeks Mixed --
Chitin-glucan + L. acidophilus NCFM 9 weeks Positive --
None -- Neutral --

أفضل وقت للتناول: On an empty stomach or before meals; may also be taken with dairy

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains)
  • Very rare: bacteremia in immunocompromised individuals

التفاعلات المعروفة

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Sulfasalazine (may affect bacterial metabolism)

الحد الأقصى المسموح به: Generally well-tolerated up to 20 billion CFU/day

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Lactobacillus acidophilus help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 350 participants, there is moderate evidence from clinical studies that Lactobacillus acidophilus may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus acidophilus should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus acidophilus?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains), Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus acidophilus and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.